aortic stenosis
Conditions
Interventions
None listed
Sponsors
Kusunose Kenya
Fujita Yuko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients who underwent transthoracic echocardiography between January 1, 2014 and December 31, 2023 at one of the participating study centers (University of the Ryukyus Hospital, Okinawa Chubu Hospital, Naha City Hospital).
Exclusion criteria
Exclusion criteria: Patients without echocardiographic data available for AI analysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age-specific prevalence of AS classified according to severity using the same criteria. Prognosis (death, cardiovascular events, hospitalization for heart failure) of AS patients classified according to severity using the same criteria. Progression of AS (changes in initial echocardiogram findings and prognosis). | — |
Secondary
| Measure | Time frame |
|---|---|
| Description of referrals to facilities capable of performing AVR. Description of referrals of AS patients to AVR facilities and their prognosis. Association between AS patient symptoms (angina/heart failure as complications, syncope/dyspnea on exertion as symptoms) and prognosis (cardiovascular events, death). Description and comparison of prognosis by severity between AS diagnosed by AI and AS diagnosed by conventional clinical practice. Description and comparison of prognosis by severity between AI-diagnosed AS and AS diagnosed through conventional clinical practice. Investigation of factors contributing to differences in AS diagnosis between AI diagnosis and conventional clinical practice (image quality, equipment, measurement errors, age, gender, body build, subjective symptoms, and other clinical backgrounds). | — |
Contacts
Public ContactKenya Kusunose
University of the Ryukyus
Outcome results
None listed